Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
398 hedge funds and large institutions have $8.54B invested in Amedisys in 2020 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 148 increasing their positions, 145 reducing their positions, and 46 closing their positions.
25% more capital invested
Capital invested by funds: $6.83B → $8.54B (+$1.71B)
11% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 46
2% more repeat investments, than reductions
Existing positions increased: 148 | Existing positions reduced: 145
0% more call options, than puts
Call options by funds: $54.8M | Put options by funds: $54.7M
0% more funds holding
Funds holding: 398 → 398 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.31% less ownership
Funds ownership: 89.03% → 88.72% (-0.31%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$94.5M |
| 2 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$55.7M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$32.2M |
| 4 |
TIM
Thornburg Investment Management
Santa Fe,
New Mexico
|
+$24.4M |
| 5 |
BlackRock
New York
|
+$23.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$46.9M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$35.2M |
| 3 |
Two Sigma Investments
New York
|
-$23.4M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$21.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$18.5M |
AMED Hedge Fund Activity: Q4 2020 in Review
398 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2020, worth a combined $8.54B — up 25% from $6.83B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new AMED positions and 46 closed out — a net gain of 5 holders — while 148 added to existing stakes and 145 trimmed.
The largest buyer was Invesco, adding an estimated $94.5M. The largest seller was Assenagon Asset Management, cutting an estimated $46.9M.
- 398 institutional investors held Amedisys (AMED) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $8.54B of Amedisys stock for Q4 2020, up 25% quarter-over-quarter.
- 51 funds opened new Amedisys positions in Q4 2020 and 46 closed out, a net change of +5 holders.
- The largest Amedisys buyer in Q4 2020 was Invesco, an estimated $94.5M added.
- The largest Amedisys seller in Q4 2020 was Assenagon Asset Management, an estimated $46.9M sold.
Based on aggregated 13F filings for Q4 2020.